The latest myeloma news
Daratumumab in multiple myeloma: Reassessment shows hint of considerable added benefit
An early benefit assessment conducted by the German Institute for Quality and Efficiency in Health…
The latest myeloma news
An early benefit assessment conducted by the German Institute for Quality and Efficiency in Health…
New results for higher dose level cohorts of the investigational study REGN5458 (BCMAxCD3) bispecific antibody,…
Patients receiving the anti-CD38 monoclonal antibody isatuximab in addition to the standard three- component induction…
The first results from the largest screening study yet conducted in the United States of…
Mount Sinai researchers in the USA have developed a new model that uses DNA and…
Patients with multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai…
To understand blood cancer, it is important to know it mainly affects the bone marrow,…
A survey by the charity Blood Cancer UK has found that over half of UK…
Bristol Myers Squibb announced that the European Commission (EC) has granted conditional marketing authorization for…
A four-drug combination therapy that includes the novel drug carfilzomib can slow the progression of…